Combined application of anti-tumor antibiotic doxorubicin and inhibitor MTOR - rapamicine restores the sensitivity of leukemia cells ТНР-1 infected with human cytomogalovirus and
- Авторлар: Chernorizh Y.Y.1, Fedorova N.E1, Yurlov K.I1, Ivanov A.V2, Kushch A.A1
-
Мекемелер:
- Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
- Engelhardt Institute of Molecular Biology RAS
- Шығарылым: Том 14, № 3 (2019)
- Беттер: 70-71
- Бөлім: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.09.2019
- URL: https://genescells.ru/2313-1829/article/view/122329
- DOI: https://doi.org/10.23868/gc122329
- ID: 122329
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Толық мәтін
Авторлар туралы
Ya. Chernorizh
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
Email: Revengeful_w@mail.ru
Moscow, Russia
N. Fedorova
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
K. Yurlov
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
A. Ivanov
Engelhardt Institute of Molecular Biology RASMoscow, Russia
A. Kushch
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
Әдебиет тізімі
Қосымша файлдар
